female scientist inspecting beaker

Research & Data

ASCO advances clinical research through scientific meetings, educational programs, and peer-reviewed journals designed to help translate research results into quality care.

  • New Telehealth in Oncology Standards

    ASCO has issued a new set of practice standards: Telehealth in Oncology. These standards provide general guidance on implementing telehealth across general and specialty settings in the oncology field.

    Learn More
  • Newly Updated HER2-Negative Metastatic Breast Cancer Guideline

    The guideline, "Chemo- and Targeted Therapy for Patients with HER2-Negative Metastatic Breast Cancer" is now available. Recommendations include immune checkpoint inhibitor may be added to chemotherapy as first-line therapy for patients with metastatic triple-negative breast cancer positive for PD-L1.

    Read More

Random Quote

"ASCO is the world’s largest and arguably most influential oncology organization… a dynamic organization that not only is advancing the frontiers of research, providing outstanding educational opportunities, and defining standards of practice for clinical care, but also influencing public policy."
Anees Chagpar, MD
ASCO Member since 2003